UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) April 25, 2005
Bone Care International, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Wisconsin | 0-27854 | 39-1527471 | ||
| (State or Other Jurisdiction | (Commission | (IRS Employer | ||
| of Incorporation) | File Number) | Identification No.) | ||
| 1600 Aspen Commons, Suite 900 | ||||
| Middleton, Wisconsin | 53562 | |||
| (Address of Principal Executive Offices) | (Zip Code) | |||
(608) 662-7800
(Registrant’s Telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
(Former Name or Former Address, if Changed Since Last Report)
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||
| o | Soliciting materials pursuant to Rule 14a-12 under the Exchange Act (CFR 240.14a-12) | |||
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (CFR 240.14d-2(b)) | |||
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (CFR 240.13e-4(c)) | |||
Item 5.02 Appointment of Principle Officer
Bone Care International, Inc. has appointed Charles W. Bishop, PhD., as Executive Vice President – Chief Scientific Officer, effective April 25, 2005.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has fully cased this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BONE CARE INTERNATIONAL, INC. |
||||
| Date: April 26, 2005 | By: | /s/ Brian J. Hayden | ||
| Brian J. Hayden | ||||
| VP Finance | ||||
3